Ryan Specialty secures $1.7 billion term loan facility

CHICAGO - Ryan Specialty Holdings, Inc. (NYSE: RYAN), a global specialty insurance organization, has announced a significant refinancing move by its subsidiary, Ryan Specialty, LLC. The company has successfully negotiated a refinancing of its existing term loan and has also increased its term loan facility to $1.7 billion. The deal is subject to the usual closing conditions and is expected to be finalized by September 13, 2024.

The new term loan facility comes with a reduced interest rate of SOFR plus 2.25%, marking a 50 basis point improvement from the previous arrangement. Additionally, the maturity date for the facility has been extended, now set to expire in 2031. The funds from this incremental term loan are intended to be used to lower the outstanding borrowings under the company's revolving credit facility.

Ryan Specialty, founded in 2010, operates by providing specialty products and solutions to insurance brokers, agents, and carriers. The company's services include distribution, underwriting, product development, administration, and risk management, acting as a wholesale broker and managing underwriter with delegated authority from insurance carriers.

This refinancing strategy could potentially enhance Ryan Specialty's financial flexibility and reduce its cost of capital, which in turn might support its mission to deliver innovative specialty insurance solutions in the industry.

The announcement includes forward-looking statements under the Private Securities Litigation Reform Act of 1995, which involve certain risks and uncertainties. These statements reflect the company's expectations regarding the refinancing and closing of the transaction and are subject to factors that could cause actual results to differ materially. Ryan Specialty has previously disclosed these risk factors in filings with the Securities and Exchange Commission.

Investors are cautioned against placing undue reliance on these forward-looking statements, which speak only as of the date of this press release. Ryan Specialty has stated it does not have an obligation to publicly update any forward-looking statement post-release, regardless of new information or future events.

This financial maneuver is based on a press release statement and is intended to provide a recap of the key facts surrounding Ryan Specialty's recent refinancing activities.

In other recent news, Ryan Specialty has been active in the financial market with significant business moves. The company upsized its senior notes offering to $600 million, an increase of $100 million from the initial announcement. The proceeds from this offering will be used to repay a portion of the borrowings under the company's revolving credit facility.

Ryan Specialty has also entered into definitive agreements to acquire the Property and Casualty managing general underwriters from Ethos Specialty Insurance and certain assets from Geo Underwriting Europe BV. These acquisitions are expected to be finalized soon, further enhancing the company's market position.

In the analysis realm, Barclays initiated coverage on Ryan Specialty Group, assigning it an Overweight rating. This rating reflects the firm's positive outlook on Ryan Specialty Group, driven by factors such as the strong market for casualty pricing and a growing economic moat amid the ongoing consolidation within the wholesale brokerage sector.

Lastly, Ryan Specialty announced a leadership succession, with Tim Turner stepping in as CEO, Jeremiah Bickham as President, and Janice Hamilton as CFO. The company has also formed strategic partnerships with MagMutual and Private Client Select. These recent developments underscore Ryan Specialty's commitment to strategic growth and financial performance.

InvestingPro Insights

As Ryan Specialty Holdings, Inc. (NYSE: RYAN) makes strategic moves to refinance its term loan facility, investors and industry observers are closely monitoring the company's financial metrics. According to InvestingPro data, Ryan Specialty boasts a market capitalization of $16.7 billion, reflecting the substantial size and influence of the company within the specialty insurance sector. The company's P/E ratio currently stands at 95.31, signaling a high valuation by the market relative to its earnings. This is further accentuated by an adjusted P/E ratio for the last twelve months as of Q2 2024 at 69.35.

InvestingPro Tips suggest that analysts are optimistic about Ryan Specialty's earnings potential, with eight analysts having revised their earnings upwards for the upcoming period. This could indicate confidence in the company's ability to grow its net income and profitability, as suggested by the tip that the company is expected to be profitable this year. Additionally, the company has shown a strong return over the last three months, with a 19.18% price total return, which may appeal to investors looking for robust performance.

It's noteworthy that Ryan Specialty is trading at a high Price / Book multiple of 27.56, which may raise questions about the sustainability of its current valuation. However, with a solid revenue growth of 19.87% over the last twelve months as of Q2 2024, the company demonstrates its ability to expand its top line effectively. For investors seeking deeper insights, there are additional InvestingPro Tips available on the platform, offering a comprehensive analysis of Ryan Specialty's financial health and future prospects.

For those interested in exploring these financial nuances further, more InvestingPro Tips can be found at https://www.investing.com/pro/RYAN, providing a valuable resource for making informed investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.